These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2543999)

  • 1. Effect of naloxone on the growth hormone response to clonidine in normal women during the mid-luteal phase.
    Phipps WR; Campbell BF; Pescovitz OH
    Psychoneuroendocrinology; 1989; 14(1-2):137-43. PubMed ID: 2543999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone enhances the increase in plasma growth hormone induced by alpha 2-adrenergic stimulation in healthy males.
    Bramnert M; Hökfelt B
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):308-13. PubMed ID: 2881420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
    Bramnert M; Hökfelt B
    J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone on the insulin and GH responses to alpha-adrenergic stimulation with clonidine.
    Massara F; Limone P; Cagliero E; Tagliabue M; Isaia GC; Molinatti GM
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):371-5. PubMed ID: 6136141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clonidine on hormone release mediated through activation of opiate receptors.
    Baranowska B
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1113-7. PubMed ID: 1964578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Naloxone doesn't determine the response of growth hormone to clonidine in obese patients].
    Satta MA; Castelli A; Maussier ML; Scoppola A; Valenza V; Saletnich I; Monaco F; Roche J
    C R Seances Soc Biol Fil; 1989; 183(4):337-41. PubMed ID: 2533520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile growth hormone release in normal women during the menstrual cycle.
    Faria AC; Bekenstein LW; Booth RA; Vaccaro VA; Asplin CM; Veldhuis JD; Thorner MO; Evans WS
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):591-6. PubMed ID: 1424184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation.
    Salat-Baroux J; Rotten D; Alvarez S; Antoine JM
    Fertil Steril; 1993 Nov; 60(5):791-9. PubMed ID: 8224263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of growth hormone status in normal young adult males using a variety of provocative agents.
    Rahim A; Toogood AA; Shalet SM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):557-62. PubMed ID: 8977752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity.
    De Marinis L; Mancini A; Folli G; D'Amico C; Corsello SM; Sciuto R; Tofani A; Sambo P; Barbarino A
    Neuroendocrinology; 1989 Nov; 50(5):529-32. PubMed ID: 2558324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol effects on naloxone-stimulated luteinizing hormone, prolactin and estradiol in women.
    Mendelson JH; Mello NK; Cristofaro P; Ellingboe J; Skupny A; Palmieri SL; Benedikt R; Schiff I
    J Stud Alcohol; 1987 Jul; 48(4):287-94. PubMed ID: 3613578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid priming effects on growth hormone response to pyridostigmine throughout the menstrual cycle.
    O'Keane V; Dinan TG
    J Clin Endocrinol Metab; 1992 Jul; 75(1):11-4. PubMed ID: 1618997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioidergic receptors in the arcuate nucleus are not involved in the cardiovascular effects of clonidine.
    Barber DA; Tackett RL
    Pharmacol Biochem Behav; 1994 Nov; 49(3):579-82. PubMed ID: 7862711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Passeri M; Zuppi P; Sambo P; Tofani A
    Metabolism; 1987 Feb; 36(2):105-9. PubMed ID: 3100909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.